The all-time high Catalent stock closing price was 125.27 on February 12, 2021. According to 12 analysts, the average rating for Catalent stock is "Strong Buy." Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. : 90 days View real-time stock prices and stock quotes for a full financial overview. View daily, weekly or monthly … Intraday Data provided by FACTSET and subject to terms of use. Privacy Notice, and 4 Vanguard ETFs That Can Double Your $1,400 Stimulus Check, Spectrum's (SPPI) NSCLC Drug Gets FDA's Fast Track Designation. CTLT | Complete Catalent Inc. stock news by MarketWatch. The average price target represents a 13.13% upside from the last price of $110.60. The Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics in clinical trials. Get the latest Catalent detailed stock quotes, stock trade data, stock price info, and performance analysis, including Catalent investment advice, charts, stats and more. The company was founded in 1933 and is headquartered in Somerset, NJ. Check the real-time CTLT stock price on the NYSE exchange and access historical data for Catalent, Inc. stock. Have Watchlists? Du kan när som helst ändra dina val i dina integritetskontroller. Catalent Inc etfs funds price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Create a list of the investments you want to track. Catalent, Inc. Common Stock (CTLT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Catalent (CTLT) Sees Hammer Chart Pattern: Time to Buy? Intraday data delayed at least 15 minutes or per exchange requirements. Catalent stock is selling for under 111.03 as of the 21st of April 2021; that is 1.53 percent increase since the beginning of the trading day. The latest closing stock price for Catalent as of April 16, 2021 is 110.60. By using this site you agree to the Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. The stock's last reported lowest price was 108.84. The Catalent 52-week high stock price is 127.68, which is 15.4% above the current share price. Check out our CTLT stock analysis, current CTLT quote, charts, and historical prices for Catalent Inc stock All quotes are in local exchange time. Stock analysis for Catalent Inc (CTLT:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile. On average, they expect Catalent's share price to reach $125.13 in the next twelve months. Discover historical prices for CTLT stock on Yahoo Finance. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Catalent against related stocks people have also bought. Historical and current end-of-day data provided by FACTSET. Company profile page for Catalent Inc including stock price, company news, press releases, executives, board members, and contact information Get Catalent Inc (CTLT:NYSE) real-time stock quotes, news, price and financial information from CNBC. For the best MarketWatch.com experience, please update to a modern browser. Catalent Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. The Biologics segment provides biologic cell-line, cell therapy and viral vector gene therapy development and manufacturing; formulation, development, and manufacturing for parenteral dose forms, which include prefilled syringes, vials, and cartridges; and analytical development and testing services for large molecules. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. During the day the stock fluctuated 4.74% from a day low at $105.17 to a day high of $110.16. The high price target for CTLT is $140.00 and the low price target for CTLT is $100.00. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Välj 'Jag godkänner' om Verizon Media får bearbeta dina personuppgifter, eller välj 'Hantera inställningar' för mer information och för att hantera dina val. Their average twelve-month price target is $125.13, predicting that the stock has a possible upside of 12.74%. Log in to see them here or sign up to get started. We split up — now he’s crying foul, Tone of next week’s U.S. economic data on track to be positive but the Fed will remain tone-deaf, Demand may exceed supply as CEO of one of the world’s biggest hotel groups sees ‘surge’ in bookings, Biden advances timeline for COVID vaccine eligibility as experts warn Americans, ‘the war is not yet won’, Contract drug maker Catalent to double production of Moderna COVID vaccine: WSJ, Emergent BioSolutions Stock Falls After Vaccine Factory Mix-Up, Perrigo Co. PLC stock rises Friday, still underperforms market, Perrigo Co. PLC stock underperforms Friday when compared to competitors, Perrigo Co. PLC stock falls Thursday, underperforms market, Perrigo Co. PLC stock falls Wednesday, underperforms market, Perrigo Co. PLC stock underperforms Tuesday when compared to competitors, Perrigo Co. PLC stock falls Friday, underperforms market, Perrigo Co. PLC stock rises Thursday, outperforms market, Perrigo Co. PLC stock outperforms market on strong trading day, Perrigo Co. PLC stock rises Tuesday, outperforms market, Perrigo Co. PLC stock rises Monday, outperforms market, Perrigo Co. PLC stock rises Wednesday, outperforms market, Perrigo Co. PLC stock falls Tuesday, underperforms market, Perrigo Co. PLC stock rises Monday, still underperforms market, Perrigo Co. PLC stock outperforms competitors despite losses on the day, Glaxo (GSK) Gets FDA Nod for Endometrial Cancer Drug Jemperli, Novo Nordisk (NVO) to Begin Study on Oral Semaglutide in Obesity, 3 Reasons to Buy Horizon Therapeutics Stock and 1 Not To, JAZZ's Xywav sNDA for Hypersomnia Gets FDA Priority Review, FibroGen (FGEN) DMD Drug Pamrevlumab Gets FDA's Fast Track Tag, Catalent (CTLT) Expands Deal With Moderna for COVID-19 Vaccine, United Therapeutics (UTHR) Gains on Tyvaso Label Expansion, Jazz's (JAZZ) Vyxeos Gets FDA Nod for Pediatric Leukemia, Time to Focus on Catalent (CTLT) for Strong Earnings Growth Potential, Translate (TBIO) Down on Unsatisfactory CF Drug Study Results, Catalyst (CPRX) Beats on Q4 Earnings, Revenues Rise Y/Y. Catalent (CTLT) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules or softgels, as well as large-scale manufacturing of oral solid dose forms for pharmaceutical and consumer health markets, and supporting ancillary services.
Woher Kommen Die Basken, Porsche Ausbildung Mannheim, Navistar News Today, See - Reich Der Blinden Staffel 2, Weichai Power Potential, Volkswagen Group Marken, Julian Reichelt Gehalt Kress, Scania Merchandise Nz, Frankfurt Bielefeld Live, Sto Perigiali Wikipedia, Copenhagen Card Louisiana Museum,